Business · 07/10/2020Updated: 10/17/2026 · 1 min read
FDA Corrects Withdrawal of COVID-19 Convalescent Plasma Guidance
Summary
The FDA is correcting a notice that withdrew a guidance for industry on COVID-19 convalescent plasma, due to the issuance of a new guidance with the same title, and correcting the incorrect docket number for the withdrawn guidance.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →